New research - Choy et al Intensified versus standard dose infliximab induction therapy for steroid-refractory acute severe ulcerative colitis (PREDICT-UC): an open-label, multicentre, randomised controlled trial https://t.co/UyrxUIahxb #IBD #GITwitter @DrMattChoy @DrChrisLi